Breast cancers at all stages are defined by the structure of their genomes, researchers find. Targeting these processes early is likely to offer unexpected therapeutic avenues.
For decades, lab-made antibodies have been used to support patients fighting specific diseases. These treatments have become ...
Homeless family had been living in van for months, parking at different casino lots before heartbreaking discovery.
UNIGE scientists have developed a groundbreaking technology that creates synthetic molecules mimicking antibodies, potentially revolutionizing disease treatments.
The following highlights showcase the most pivotal, innovative research published across multiple therapeutic areas in ...
As global markets grapple with tariff uncertainties and mixed economic signals, major indices such as the S&P 500 and Nasdaq Composite have shown modest declines, reflecting investor caution amid ...
Background: Variable rates of HER2 protein overexpression and gene amplification have been reported in advanced ovarian cancers (AOC). Trastuzumab, tested only as a single agent, has been shown to ...
PHOENIX (AZFamily) — Trial began on Monday for a Tempe mom accused of killing her two children four years ago. Prosecutors say the murder weapon was a meat cleaver and the mom, Yui Inoue ...
This innovative model preserves the characteristics of ... Trastuzumab Emtansine Improves Long-Term Survival in HER2 Breast Cancer Jan. 15, 2025 — In patients with high-risk HER2-positive breast ...
Olaparib for treating BRCA mutation-positive HER2-negative advanced breast cancer after chemotherapy
There is a commercial access agreement for olaparib. NHS organisations can get details on the Commercial Access and Pricing (CAP) Portal. Non-NHS organisations can contact ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results